Marker Gene Technologies

EUGENE, OR 97403

SBIR Award Summary

Total Number of Awards 15
Total Value of Awards $3.34MM
First Award Date 09/01/96
Most Recent Award Date 08/01/17

Key Personnel

Last Name Name Awards Contact
Naleway John J Naleway 15

15 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 08/01/17 - 07/31/18

PROJECT SUMMARY/ABSTRACT This Small Business Innovation Research Phase II project aims to develop new targeted fluorogenic substrates capable of measuring enzyme activities in the Golgi apparatus and Endoplasmic Reticulum (ER) of living cells and tissues. The ultimate goal and the overall impact of this project is to provide an understanding of...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 07/01/15 - 06/30/16

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop new targeted pharmacological chaperones capable of modulating enzyme degradation in the Golgi apparatus and Endoplasmic Reticulum (ER) of living cells and tissues. If successful, the proposed research will provide breakthroughs needed to ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-062
Budget: 03/01/14 - 02/28/15

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase II project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in living cells and tissues. If successful, the proposed research will provide breakthroughs needed to advance the discovery of promising new therapies an...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/13 - 02/28/14

DESCRIPTION: This Small Business Innovation Research Phase I project aims to develop new targeted fluorogenic substrates capable of measuring enzyme activities in the Golgi apparatus and Endoplasmic Reticulum (ER) of living cells and tissues. If successful, the proposed research will provide breakthroughs needed to advance the discovery of promi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-062
Budget: 03/01/13 - 02/28/14

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase II project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in living cells and tissues. If successful, the proposed research will provide breakthroughs needed to advance the discovery of promising new therapies an...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-062
Budget: 03/01/12 - 02/28/13

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase II project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in living cells and tissues. If successful, the proposed research will provide breakthroughs needed to advance the discovery of promising new therapies an...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 01/01/08 - 12/31/09

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in living cells and tissues. If successful, the proposed research will provide breakthroughs needed to advance the discovery of promising new therapies and...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 01/01/07 - 12/31/07

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in living cells and tissues. If successful, the proposed research will provide breakthroughs needed to advance the discovery of promising new therapies and...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/05 - 03/31/08

This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new compounds capable of utilizing common marker gene expression in transformed cells to control the growth and character of cells in cell culture and live tissue applications. If successful, the proposed research will provide breakthroughs ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/02 - 09/29/03

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new compounds capable of utilizing common marker gene expression in transformed cells to control the growth and character of cells in living tissue. If successful, the proposed research will provide break...

Load More